Literature DB >> 12377840

Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation.

David R Nunley1, Anthony A Gal, J David Vega, Carl Perlino, Pauline Smith, E Clinton Lawrence.   

Abstract

STUDY
OBJECTIVE: To demonstrate an association between saprophytic fungal infections occurring at the bronchial anastomosis (BA) and the development of additional complications arising at this site.
DESIGN: Retrospective review.
SETTING: University lung transplant center.
MATERIALS AND METHODS: Review of all single-lung and double-lung transplant (LTX) recipients who underwent transplantation between June 1993 and December 2000. All recipients were subjected to surveillance bronchoscopy with biopsy at predetermined intervals and when clinically indicated. Bronchial wash fluid and biopsy material were examined using appropriate fungal stains and culture techniques. An infection was defined when fungal organisms were identified in tissue specimens.
RESULTS: Fifteen saprophytic fungal infections involving the BA were identified in 61 LTX recipients (24.6%) who survived a minimum of 75 days post-transplantation. Infections were attributed to Aspergillus sp (n = 9), Candida sp (n = 2), Torulopsis sp (n = 1), and mixed flora (ie, Penicillium + Candida, two patients; and Aspergillus + Candida, one patient). Saprophytic fungal infections occurred by a median of postoperative day 35 (range, 13 to 159 days). Airway complications involving the BA ultimately developed in 11 of 61 recipients (18%). These complications included symptomatic bronchial stenosis (nine patients), bronchomalacia (one patient), and fatal hemorrhage (one patient). Bronchial complications arose in 7 of 15 recipients (46.7%) with saprophytic fungal infections of the BA in contrast to 4 of 46 (8.7%) without infections (p = 0.003, Fisher exact test). Also demonstrated was a positive correlation between anastomotic infections and bronchial complications (Phi coefficient = 0.43; p = 0.001), while logistic regression analysis revealed that the absence of anastomotic infections predicted the absence of such complications (p = 0.002). The risk of developing an additional complication following an anastomotic infection in patients with infections was five times that of those recipients without an infection (relative risk, 5.36; 95% confidence interval [CI], 1.82 to 15.79). The odds in favor of a bronchial complication following an infection were eight times greater than in those recipients without infection (odds ratio, 8.31; 95% CI, 1.96 to 35.16).
CONCLUSIONS: Following LTX, saprophytic fungal infections of the BA are associated with serious airway complications.

Entities:  

Mesh:

Year:  2002        PMID: 12377840     DOI: 10.1378/chest.122.4.1185

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

Review 1.  Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.

Authors:  Michael D Duncan; David S Wilkes
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Fatal bronchovascular fistula after lobectomy visualized through postmortem computed tomography angiography: A case report.

Authors:  Philipp Hinderberger; Barbara Fliss; Michael J Thali; Wolf Schweitzer
Journal:  Forensic Sci Med Pathol       Date:  2017-04-11       Impact factor: 2.007

Review 3.  Infections after lung transplantation.

Authors:  Mario Nosotti; Paolo Tarsia; Letizia Corinna Morlacchi
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 4.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

5.  Safety of hyperbaric oxygen therapy for management of central airway stenosis after lung transplant.

Authors:  Kamran Mahmood; Bryan D Kraft; Kristen Glisinski; Matthew G Hartwig; Nicole P Harlan; Claude A Piantadosi; Scott L Shofer
Journal:  Clin Transplant       Date:  2016-08-02       Impact factor: 2.863

6.  Significance of and risk factors for the development of central airway stenosis after lung transplantation.

Authors:  S L Shofer; M M Wahidi; W A Davis; S M Palmer; M G Hartwig; Y Lu; L D Snyder
Journal:  Am J Transplant       Date:  2012-12-27       Impact factor: 8.086

7.  Relevance of GERD in lung transplant patients.

Authors:  Veerle Mertens; Lieven Dupont; Daniel Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2010-06

Review 8.  Fungal Infections After Lung Transplantation.

Authors:  Cassie C Kennedy; Raymund R Razonable
Journal:  Clin Chest Med       Date:  2017-05-20       Impact factor: 2.878

9.  A comparative analysis of bronchial stricture after lung transplantation in recipients with and without early acute rejection.

Authors:  Anthony W Castleberry; Mathias Worni; Maragatha Kuchibhatla; Shu S Lin; Laurie D Snyder; Scott L Shofer; Scott M Palmer; Ricardo Pietrobon; R Duane Davis; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2013-07-18       Impact factor: 4.330

10.  Fatal bronchovascular fistula after a single lung transplantation: a case report.

Authors:  Marcos Naoyuki Samano; Juliana Akemi Saka; Marlova Luzzi Caramori; Paulo Manuel Pêgo-Fernandes; Fabio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.